Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S W Tan

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2023
Liquid Biopsies for Cancer Genotyping: Coming of Age?Anders Jacobsen Skanderup, Su Fen Ang, Daniel S W Tan
Cancer Discovery|July 7, 2023
Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung CancerSarina Z W Heng, Regina Hoo, Daniel S W Tan
The New England Journal of Medicine|November 20, 2014
Carcinoma of unknown primary siteAmit Jain, Tira J Y Tan, Daniel S W Tan
European Journal of Cancer (Oxford, England : 1990)|April 24, 2010
Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interferenceDaniel S-W Tan, Marco Gerlinger, Bin-Tean Teh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Cancer Genomics: Diversity and Disparity Across Ethnicity and GeographyDaniel S W Tan, Tony S K Mok, Timothy R Rebbeck
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedsideDavid Olmos, Daniel S W Tan, Robin L Jones, et al.
Annals of Translational Medicine|October 24, 2017
Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancerKah Weng Lau, Claudia Seng, Tony K H Lim, et al.
Nature Reviews. Clinical Oncology|November 15, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Improving Precision and Implementation of Immuno-Oncology BiomarkersLisda Suteja, Joe Yeong, Aaron C Tan, et al.
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2023
Liquid Biopsies for Cancer Genotyping: Coming of Age?Anders Jacobsen Skanderup, Su Fen Ang, Daniel S W Tan
Cancer Discovery|July 7, 2023
Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung CancerSarina Z W Heng, Regina Hoo, Daniel S W Tan
The New England Journal of Medicine|November 20, 2014
Carcinoma of unknown primary siteAmit Jain, Tira J Y Tan, Daniel S W Tan
European Journal of Cancer (Oxford, England : 1990)|April 24, 2010
Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interferenceDaniel S-W Tan, Marco Gerlinger, Bin-Tean Teh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Cancer Genomics: Diversity and Disparity Across Ethnicity and GeographyDaniel S W Tan, Tony S K Mok, Timothy R Rebbeck
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedsideDavid Olmos, Daniel S W Tan, Robin L Jones, et al.
Annals of Translational Medicine|October 24, 2017
Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancerKah Weng Lau, Claudia Seng, Tony K H Lim, et al.
Nature Reviews. Clinical Oncology|November 15, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Improving Precision and Implementation of Immuno-Oncology BiomarkersLisda Suteja, Joe Yeong, Aaron C Tan, et al.
Pageof 15